Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis

Completed · Phase 4

Conditions studied: Continuous Ambulatory Peritoneal Dialysis, End Stage Renal Disease

In brief

The objective of this study is to characterize the pharmacokinetic profile of ertapenem during continuous ambulatory peritoneal dialysis (CAPD).

Key facts

Study ID

NCT00939952

Run by

Albany College of Pharmacy and Health Sciences

People needed

7

Starts

2009-06-01

Expected to finish

2010-05-01

Last updated by the study team

2013-02-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Hortense and Louis Rubin Dialysis Center — Clifton Park, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.